Medical Affairs Outsourcing Market Size to Surpass USD 4.18 Billion by 2035 | SNS Insider

The U.S. Medical Affairs Outsourcing Market is projected to grow from USD 0.64 Billion in 2025 to USD 1.06 Billion by 2035, while Europe is expected to expand from USD 0.67 Billion to USD 2.41 Billion, supported by increasing clinical trial complexity, regulatory requirements, and pharmacovigilance outsourcing demand.

The U.S. Medical Affairs Outsourcing Market is projected to grow from USD 0.64 Billion in 2025 to USD 1.06 Billion by 2035, while Europe is expected to expand from USD 0.67 Billion to USD 2.41 Billion, supported by increasing clinical trial complexity, regulatory requirements, and pharmacovigilance outsourcing demand.

DEEP SEA MINERALS CORP. WELCOMES G7 LEADERS’ DECLARATION ON SECURING CRITICAL MINERALS SUPPLY CHAINS

Vancouver, British Columbia, June 22, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCQB: DSEAF) (FSE: X450) (“Deep Sea Minerals” or the “Company“), a seabed mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, today welcomed the G7 leaders’ declaration on securing supply chains for critical minerals, which underscores the strategic importance of diversified, transparent, and resilient critical minerals supply chains.

Quantum Cyber Issues Letter to Shareholders

Capitol Hill Meetings with Rep. McCormick and Senior Officials | Pentagon City Defense Conference | Connecticut Facility Purchase Agreement in Progress | Strong Financial Position

Capitol Hill Meetings with Rep. McCormick and Senior Officials | Pentagon City Defense Conference | Connecticut Facility Purchase Agreement in Progress | Strong Financial Position

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN, CHINA, June 22, 2026 (GLOBE NEWSWIRE) — China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Injection (GR1801, the “Product”), a Class 1 therapeutic biological product has been approved by the National Medical Products Administration of the People’s Republic of China (“NMPA”) and the drug registration certificate was obtained on 22 June 2026. The Product is indicated for passive immunization in adults following rabies virus exposure.

AI Clinical Documentation Market Size to Reach USD 12.78 Billion by 2035 | SNS Insider

The U.S. AI Clinical Documentation Market is projected to grow from USD 0.41 Billion in 2025 to USD 3.96 Billion by 2035, while Europe is expected to reach USD 5.15 Billion from USD 0.42 Billion, supported by rising adoption of ambient AI, generative AI, and automated clinical documentation solutions across healthcare systems.

The U.S. AI Clinical Documentation Market is projected to grow from USD 0.41 Billion in 2025 to USD 3.96 Billion by 2035, while Europe is expected to reach USD 5.15 Billion from USD 0.42 Billion, supported by rising adoption of ambient AI, generative AI, and automated clinical documentation solutions across healthcare systems.

Can-Fite Publishes Peer-Reviewed Scientific Article Demonstrating the Broad Therapeutic Potential of Piclidenoson and Namodenoson

Ramat-Gan, Israel, June 22, 2026 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced the publication of a peer-reviewed scientific article demonstrating the broad therapeutic potential of its lead drug candidates, Piclidenoson and Namodenoson, across multiple major diseases.

Low-rise new home sales in GTA beat 10-year average for second consecutive month thanks to HST rebate

Toronto, June 22, 2026 (GLOBE NEWSWIRE) — New home buyers in the Greater Toronto Area (GTA) continue to respond positively to the enhanced HST rebate program as low-rise new home sales outperformed its 10-year average for a second consecutive month in May, the Building Industry and Land Development Association (BILD) said today. The HST rebate program remains a historic buying opportunity for those looking to purchase a new home. However, in May the need for clarity on how rebates are administered contributed to some potential buyers delaying purchasing decisions.

Activated Alumina Market Size to Surpass USD 2.26 Billion by 2035 as Global Demand for Water Treatment Solutions Grows | SNS Insider

U.S. Market Projected to Reach USD 0.60 Billion by 2035, While Europe Approaches USD 0.57 Billion Amid Rising Investments in Water Purification and Environmental Compliance

U.S. Market Projected to Reach USD 0.60 Billion by 2035, While Europe Approaches USD 0.57 Billion Amid Rising Investments in Water Purification and Environmental Compliance

AI in Chemicals Market Size to Hit $25.89 Billion by 2035 as Smart Manufacturing and AI-Driven Process Optimization Accelerate | Research by SNS Insider

The U.S. AI in Chemicals Market is Expected to Reach $6.98 Billion by 2035, While Europe is Projected to Touch $5.89 Billion, Driven by AI-Powered Production Optimization, Sustainable Chemical Manufacturing, Predictive Analytics, and Rising Investments in Digital Transformation Across the Chemical Industry

The U.S. AI in Chemicals Market is Expected to Reach $6.98 Billion by 2035, While Europe is Projected to Touch $5.89 Billion, Driven by AI-Powered Production Optimization, Sustainable Chemical Manufacturing, Predictive Analytics, and Rising Investments in Digital Transformation Across the Chemical Industry